Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCO
1901
DELISTED
Patterson Companies, Inc.
PDCO
| $3.81M | ﹤0.01% |
130,005
+49,872
| +62% | +$1.56M |
|
1902
Liberty Global Class A
LBTYA
$3.71B
| $3.81M | ﹤0.01% |
137,501
-67,659
| -33% | -$1.92M |
|
1903
PTC Therapeutics
PTCT
$5.68B
| $3.81M | ﹤0.01% |
95,742
+36,302
| +61% | +$1.39M |
|
1904
CALL
Atlassian
TEAM
$26.3B
| $3.81M | ﹤0.01% |
+10,000
| New | +$4.02M |
|
1905
Encompass Health
EHC
$11.2B
| $3.8M | ﹤0.01% |
73,272
-208,154
| -74% | -$10.7M |
|
1906
Middlesex Water
MSEX
$1.07B
| $3.8M | ﹤0.01% |
31,584
+8,215
| +35% | +$873K |
|
|
CSGS
1907
DELISTED
CSG Systems International
CSGS
| $3.8M | ﹤0.01% |
65,920
+7,375
| +13% | +$391K |
|
1908
Acadia Pharmaceuticals
ACAD
$4.39B
| $3.79M | ﹤0.01% |
162,338
+59,386
| +58% | +$1.19M |
|
1909
Paylocity
PCTY
$7.48B
| $3.79M | ﹤0.01% |
16,029
-8,813
| -35% | -$2.34M |
|
1910
CALL
Cboe Global Markets
CBOE
$31.2B
| $3.78M | ﹤0.01% |
+29,000
| New | +$3.74M |
|
1911
AtriCure
ATRC
$1.97B
| $3.78M | ﹤0.01% |
54,378
+22,379
| +70% | +$1.63M |
|
1912
ArcelorMittal
MT
$54.2B
| $3.78M | ﹤0.01% |
118,707
-105,001
| -47% | -$3.25M |
|
1913
Gentherm
THRM
$1.28B
| $3.77M | ﹤0.01% |
43,432
+9,866
| +29% | +$830K |
|
|
FOLD
1914
DELISTED
Amicus Therapeutics
FOLD
| $3.77M | ﹤0.01% |
326,259
-125,879
| -28% | -$1.4M |
|
1915
Vicor
VICR
$9.85B
| $3.76M | ﹤0.01% |
29,633
+12,687
| +75% | +$1.8M |
|
|
QVCGA
1916
DELISTED
QVC Group Inc Series A
QVCGA
| $3.76M | ﹤0.01% |
9,899
+5,931
| +149% | +$2.68M |
|
1917
Itaú Unibanco
ITUB
$93.6B
| $3.75M | ﹤0.01% |
1,133,961
-218,902
| -16% | -$788K |
|
1918
PUT
AbbVie
ABBV
$433B
| $3.75M | ﹤0.01% |
27,700
-20,000
| -42% | -$2.36M |
|
1919
First Industrial Realty Trust
FR
$8.69B
| $3.74M | ﹤0.01% |
56,522
-163,456
| -74% | -$9.84M |
|
1920
SPX Corp
SPXC
$10.7B
| $3.74M | ﹤0.01% |
62,704
-9,582
| -13% | -$580K |
|
1921
Cohen & Steers
CNS
$4.35B
| $3.73M | ﹤0.01% |
40,377
+9,259
| +30% | +$857K |
|
1922
CALL
Canadian National Railway
CNI
$76.1B
| $3.72M | ﹤0.01% |
30,300
-67,600
| -69% | -$8.56M |
|
1923
Diamondrock Hospitality Co
DRH
$2.74B
| $3.72M | ﹤0.01% |
387,409
-14,741
| -4% | -$139K |
|
1924
PUT
Thor Industries
THO
$4.03B
| $3.71M | ﹤0.01% |
+35,800
| New | +$3.88M |
|
|
SAVE
1925
DELISTED
Spirit Airlines, Inc.
SAVE
| $3.71M | ﹤0.01% |
169,931
+32,745
| +24% | +$761K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.